Form 4: MAXIMUS Officer Ilene Baylinson Reports Accrual of Dividend Equivalent Rights
Insider Transaction Report
MAXIMUS, Inc. General Manager Ilene Baylinson reported the acquisition of 156.865 dividend equivalent rights, bringing her total beneficial ownership to 38,071.289 derivative securities.
Summary
- Ilene R. Baylinson, General Manager Health & Human at MAXIMUS, INC. (MMS), reported an acquisition transaction on May 31, 2025.
- She acquired 156.865 Dividend Equivalent Rights (DERs) at a price of $0.
- These DERs accrued on previously-awarded restricted stock units (RSUs) and performance share units (PSUs) for which the performance criteria have been met.
- Each dividend equivalent right is the economic equivalent of one share of Maximus Common Stock.
- Following this reported transaction, Ms. Baylinson beneficially owns a total of 38,071.289 derivative securities.
Sentiment
Score: 6
Explanation: The accrual of dividend equivalent rights is a positive indicator that performance criteria for executive compensation have been met, aligning executive interests with shareholder value, though it's a routine compensation event rather than a significant new development.
Positives
- The accrual of dividend equivalent rights indicates that performance criteria for previously awarded performance share units have been met, suggesting positive company performance or achievement of specific goals.
- The increase in beneficial ownership of derivative securities further aligns the officer's financial interests with those of the company's shareholders.
Future Outlook
N/A
Industry Context
This filing is a routine insider transaction report, common across all industries for publicly traded companies, reflecting the structure of executive compensation plans. It does not provide specific insights into broader industry trends or competitive dynamics.
Stakeholder Impact
- Shareholders: The accrual of dividend equivalent rights for an officer aligns their interests with shareholders, as these rights are tied to the company's common stock and are contingent on performance criteria being met.
Key Dates
| Date | Description |
|---|---|
| 05/31/2025 | Date of earliest transaction for the acquisition of Dividend Equivalent Rights. |
| 06/03/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Keywords
MAXIMUS, MMS, SEC Form 4, Insider Transaction, Dividend Equivalent Rights, Restricted Stock Units, Performance Share Units, Executive Compensation, Ilene Baylinson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.